Cargando…
Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia
BACKGROUND: Neuroinflammation is involved in the mechanisms of levodopa-induced dyskinesia (LID). The canonical NF-κB activation signaling pathway plays a critical role in the neuroinflammation development and BET protein-induced NF-κB-mediated neuroinflammation. The inhibition of the BET protein fu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253514/ https://www.ncbi.nlm.nih.gov/pubmed/35801173 http://dx.doi.org/10.3389/fnins.2022.896322 |
_version_ | 1784740506302939136 |
---|---|
author | Wan, Ying Han, Li Rong, Lu Yang, Shuyuan Song, Lu Wu, Na Liu, Zhenguo Gan, Jing |
author_facet | Wan, Ying Han, Li Rong, Lu Yang, Shuyuan Song, Lu Wu, Na Liu, Zhenguo Gan, Jing |
author_sort | Wan, Ying |
collection | PubMed |
description | BACKGROUND: Neuroinflammation is involved in the mechanisms of levodopa-induced dyskinesia (LID). The canonical NF-κB activation signaling pathway plays a critical role in the neuroinflammation development and BET protein-induced NF-κB-mediated neuroinflammation. The inhibition of the BET protein function has been reported to alleviate LID; however, its association with the canonical NF-κB signaling pathway in the 6-OHDA-lesioned striatum of the LID rat model remains unknown. Accordingly, we identified the status of the canonical NF-κB signaling pathway in the 6-OHDA-lesioned striatum of the LID rat model and whether the anti-dyskinetic effect of the BET inhibitor JQ1 was associated with its suppression on NF-κB-mediated neuroinflammation. METHODS: 6-OHDA PD rat models were treated with either L-dopa plus JQ1 or L-dopa alone. L-dopa treatment was given for 2 weeks, and the JQ1 treatment was given for 3 weeks and was initiated a week prior to L-dopa treatment. As a control, the sham rats were treated with JQ1 or Veh for 3 weeks. The ALO AIM assessment and cylinder test were performed during the treatment. Glial activation markers, pro-inflammatory substances, and critical proteins in the canonical NF-κB signaling pathway were tested in the lesioned striatum after the final treatment. RESULTS: JQ1 effectively alleviated LID without influencing motor improvement. In the lesioned striatum, L-dopa triggered an overactivation of the canonical NF-κB signaling pathway, with an increase in the phospho-IKKα/β, phospho-IκBα, and NF-κB nuclear translocation and its phosphorylation at Ser 536 and Ser 276 sites (p < 0.01 vs. sham group). L-dopa induced an overexpression of the pro-inflammatory substances of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and inducible nitric oxide synthase (iNOS), and the glial activation markers CD68 and GFAP. All the molecular changes were greatly inhibited by JQ1. CONCLUSION: L-dopa triggered an overactivation of the canonical NF-κB signaling pathway, leading to an enhanced neuroinflammation response in the 6-OHDA-lesioned striatum of LID rat models. The inhibition of the BET protein function significantly suppressed the activation of the canonical NF-κB signaling pathway in the striatum, alleviating the neuroinflammation response and the severity of LID. |
format | Online Article Text |
id | pubmed-9253514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92535142022-07-06 Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia Wan, Ying Han, Li Rong, Lu Yang, Shuyuan Song, Lu Wu, Na Liu, Zhenguo Gan, Jing Front Neurosci Neuroscience BACKGROUND: Neuroinflammation is involved in the mechanisms of levodopa-induced dyskinesia (LID). The canonical NF-κB activation signaling pathway plays a critical role in the neuroinflammation development and BET protein-induced NF-κB-mediated neuroinflammation. The inhibition of the BET protein function has been reported to alleviate LID; however, its association with the canonical NF-κB signaling pathway in the 6-OHDA-lesioned striatum of the LID rat model remains unknown. Accordingly, we identified the status of the canonical NF-κB signaling pathway in the 6-OHDA-lesioned striatum of the LID rat model and whether the anti-dyskinetic effect of the BET inhibitor JQ1 was associated with its suppression on NF-κB-mediated neuroinflammation. METHODS: 6-OHDA PD rat models were treated with either L-dopa plus JQ1 or L-dopa alone. L-dopa treatment was given for 2 weeks, and the JQ1 treatment was given for 3 weeks and was initiated a week prior to L-dopa treatment. As a control, the sham rats were treated with JQ1 or Veh for 3 weeks. The ALO AIM assessment and cylinder test were performed during the treatment. Glial activation markers, pro-inflammatory substances, and critical proteins in the canonical NF-κB signaling pathway were tested in the lesioned striatum after the final treatment. RESULTS: JQ1 effectively alleviated LID without influencing motor improvement. In the lesioned striatum, L-dopa triggered an overactivation of the canonical NF-κB signaling pathway, with an increase in the phospho-IKKα/β, phospho-IκBα, and NF-κB nuclear translocation and its phosphorylation at Ser 536 and Ser 276 sites (p < 0.01 vs. sham group). L-dopa induced an overexpression of the pro-inflammatory substances of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and inducible nitric oxide synthase (iNOS), and the glial activation markers CD68 and GFAP. All the molecular changes were greatly inhibited by JQ1. CONCLUSION: L-dopa triggered an overactivation of the canonical NF-κB signaling pathway, leading to an enhanced neuroinflammation response in the 6-OHDA-lesioned striatum of LID rat models. The inhibition of the BET protein function significantly suppressed the activation of the canonical NF-κB signaling pathway in the striatum, alleviating the neuroinflammation response and the severity of LID. Frontiers Media S.A. 2022-06-21 /pmc/articles/PMC9253514/ /pubmed/35801173 http://dx.doi.org/10.3389/fnins.2022.896322 Text en Copyright © 2022 Wan, Han, Rong, Yang, Song, Wu, Liu and Gan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Wan, Ying Han, Li Rong, Lu Yang, Shuyuan Song, Lu Wu, Na Liu, Zhenguo Gan, Jing Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia |
title | Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia |
title_full | Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia |
title_fullStr | Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia |
title_full_unstemmed | Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia |
title_short | Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia |
title_sort | inhibition of bet protein function suppressed the overactivation of the canonical nf-κb signaling pathway in 6-ohda-lesioned rat model of levodopa-induced dyskinesia |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253514/ https://www.ncbi.nlm.nih.gov/pubmed/35801173 http://dx.doi.org/10.3389/fnins.2022.896322 |
work_keys_str_mv | AT wanying inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia AT hanli inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia AT ronglu inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia AT yangshuyuan inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia AT songlu inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia AT wuna inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia AT liuzhenguo inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia AT ganjing inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia |